These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 25220467)
1. P7C3 neuroprotective chemicals block axonal degeneration and preserve function after traumatic brain injury. Yin TC; Britt JK; De Jesús-Cortés H; Lu Y; Genova RM; Khan MZ; Voorhees JR; Shao J; Katzman AC; Huntington PJ; Wassink C; McDaniel L; Newell EA; Dutca LM; Naidoo J; Cui H; Bassuk AG; Harper MM; McKnight SL; Ready JM; Pieper AA Cell Rep; 2014 Sep; 8(6):1731-1740. PubMed ID: 25220467 [TBL] [Abstract][Full Text] [Related]
2. Early detection of subclinical visual damage after blast-mediated TBI enables prevention of chronic visual deficit by treatment with P7C3-S243. Dutca LM; Stasheff SF; Hedberg-Buenz A; Rudd DS; Batra N; Blodi FR; Yorek MS; Yin T; Shankar M; Herlein JA; Naidoo J; Morlock L; Williams N; Kardon RH; Anderson MG; Pieper AA; Harper MM Invest Ophthalmol Vis Sci; 2014 Dec; 55(12):8330-41. PubMed ID: 25468886 [TBL] [Abstract][Full Text] [Related]
3. P7C3-A20 treatment one year after TBI in mice repairs the blood-brain barrier, arrests chronic neurodegeneration, and restores cognition. Vázquez-Rosa E; Shin MK; Dhar M; Chaubey K; Cintrón-Pérez CJ; Tang X; Liao X; Miller E; Koh Y; Barker S; Franke K; Crosby DR; Schroeder R; Emery J; Yin TC; Fujioka H; Reynolds JD; Harper MM; Jain MK; Pieper AA Proc Natl Acad Sci U S A; 2020 Nov; 117(44):27667-27675. PubMed ID: 33087571 [TBL] [Abstract][Full Text] [Related]
4. Neuroprotective efficacy of a proneurogenic compound after traumatic brain injury. Blaya MO; Bramlett HM; Naidoo J; Pieper AA; Dietrich WD J Neurotrauma; 2014 Mar; 31(5):476-86. PubMed ID: 24070637 [TBL] [Abstract][Full Text] [Related]
5. P7C3 neuroprotective chemicals function by activating the rate-limiting enzyme in NAD salvage. Wang G; Han T; Nijhawan D; Theodoropoulos P; Naidoo J; Yadavalli S; Mirzaei H; Pieper AA; Ready JM; McKnight SL Cell; 2014 Sep; 158(6):1324-1334. PubMed ID: 25215490 [TBL] [Abstract][Full Text] [Related]
6. Neurotherapeutic capacity of P7C3 agents for the treatment of Traumatic Brain Injury. Blaya MO; Wasserman JM; Pieper AA; Sick TJ; Bramlett HM; Dietrich WD Neuropharmacology; 2019 Feb; 145(Pt B):268-282. PubMed ID: 30236963 [TBL] [Abstract][Full Text] [Related]
7. P7C3-A20 neuroprotection is independent of Wallerian degeneration in primary neuronal culture. Hill CS; Menon DK; Coleman MP Neuroreport; 2018 Dec; 29(18):1544-1549. PubMed ID: 30334859 [TBL] [Abstract][Full Text] [Related]
8. (-)-P7C3-S243 Protects a Rat Model of Alzheimer's Disease From Neuropsychiatric Deficits and Neurodegeneration Without Altering Amyloid Deposition or Reactive Glia. Voorhees JR; Remy MT; Cintrón-Pérez CJ; El Rassi E; Khan MZ; Dutca LM; Yin TC; McDaniel LN; Williams NS; Brat DJ; Pieper AA Biol Psychiatry; 2018 Oct; 84(7):488-498. PubMed ID: 29246437 [TBL] [Abstract][Full Text] [Related]
9. P7C3 and an unbiased approach to drug discovery for neurodegenerative diseases. Pieper AA; McKnight SL; Ready JM Chem Soc Rev; 2014 Oct; 43(19):6716-26. PubMed ID: 24514864 [TBL] [Abstract][Full Text] [Related]
10. Neuroprotective Efficacy of an Aminopropyl Carbazole Derivative P7C3-A20 in Ischemic Stroke. Wang SN; Xu TY; Wang X; Guan YF; Zhang SL; Wang P; Miao CY CNS Neurosci Ther; 2016 Sep; 22(9):782-8. PubMed ID: 27333812 [TBL] [Abstract][Full Text] [Related]
11. Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of Parkinson disease. De Jesús-Cortés H; Xu P; Drawbridge J; Estill SJ; Huntington P; Tran S; Britt J; Tesla R; Morlock L; Naidoo J; Melito LM; Wang G; Williams NS; Ready JM; McKnight SL; Pieper AA Proc Natl Acad Sci U S A; 2012 Oct; 109(42):17010-5. PubMed ID: 23027934 [TBL] [Abstract][Full Text] [Related]
12. The neuroprotective compound P7C3-A20 promotes neurogenesis and improves cognitive function after ischemic stroke. Loris ZB; Pieper AA; Dietrich WD Exp Neurol; 2017 Apr; 290():63-73. PubMed ID: 28077334 [TBL] [Abstract][Full Text] [Related]
13. Discovery of a neuroprotective chemical, (S)-N-(3-(3,6-dibromo-9H-carbazol-9-yl)-2-fluoropropyl)-6-methoxypyridin-2-amine [(-)-P7C3-S243], with improved druglike properties. Naidoo J; De Jesus-Cortes H; Huntington P; Estill S; Morlock LK; Starwalt R; Mangano TJ; Williams NS; Pieper AA; Ready JM J Med Chem; 2014 May; 57(9):3746-54. PubMed ID: 24697290 [TBL] [Abstract][Full Text] [Related]
14. GSK-3 inhibition through GLP-1R allosteric activation mediates the neurogenesis promoting effect of P7C3 after cerebral ischemic/reperfusional injury in mice. Wang YH; Liou KT; Tsai KC; Liu HK; Yang LM; Chern CM; Shen YC Toxicol Appl Pharmacol; 2018 Oct; 357():88-105. PubMed ID: 30189238 [TBL] [Abstract][Full Text] [Related]
15. P7C3 Attenuates the Scopolamine-Induced Memory Impairments in C57BL/6J Mice. Jiang B; Song L; Huang C; Zhang W Neurochem Res; 2016 May; 41(5):1010-9. PubMed ID: 26646000 [TBL] [Abstract][Full Text] [Related]